Breast Cancer - Cancer PHGKB -

Genomics and Precision Health Weekly Update | CDC

What's New

Last Posted: Sep 04, 2020

---

• Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program. 
  White Randie E et al. The breast journal 2020 Sep
• Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib. 
  Kim Ji-Yeon et al. Breast cancer research and treatment 2020 Aug
• Frequency and Association Of GSTM1 and GSTT1 Gene Polymorphisms with Survival in Breast Cancer Patients. 
  Tangkhuenkhan Phakarat et al. Asian Pacific journal of cancer prevention : APJCP 2020 Aug 21(8) 2251-2257
• Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History. 
  van den Broek Jeroen J et al. Journal of the National Cancer Institute 2020 Aug
• Screening women at high risk for breast cancer: one program fits all? : Subgroup analysis of a large population high risk breast screening program. 
  Hermann Naama et al. Breast cancer research and treatment 2020 Aug
• Color Doppler Ultrasound Improves Machine Learning Diagnosis of Breast Cancer. 
  Moustafa Afaf F et al. Diagnostics (Basel, Switzerland) 2020 Aug 10(9)
• Mutation in Exon2 of BRCA1 Gene in Adult Bengali Bangladeshi Female Patients with Breast Cancer: An Experience from Two Tertiary-Care Hospitals. 
  Chowdhury Sagana Shahreen et al. Asian Pacific journal of cancer prevention : APJCP 2020 Aug 21(8) 2265-2270
• External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening Mammograms 
  JM Salim et al, JAMA Oncology, August 27, 2020
• Implications of CLSPN Variants in Cellular Function and Susceptibility to Cancer. 
  Azenha Diana et al. Cancers 2020 Aug 12(9)
• A Pre-Test-Post-Test Trial of a Breast Cancer Risk Report for Women in Their 40s. 
  Schonberg Mara A et al. American journal of preventive medicine 2020 Sep 59(3) 343-354
• Clinical implications of prospective genomic profiling of metastatic breast cancer patients. 
  van Geelen Courtney T et al. Breast cancer research : BCR 2020 Aug 22(1) 91
• Clinicopathologic features of breast cancer reclassified as HER2-amplified by fluorescence in situ hybridization with alternative chromosome 17 probes. 
  Blanton Kristen C et al. Annals of diagnostic pathology 2020 Aug 48151576
• Differences in Breast and Cervical Cancer Screening Among U.S. Women by Nativity and Family History. 
  Donley Tiffany et al. American journal of preventive medicine 2020 Aug
• Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age. 
  Bernhardt Sarah M et al. Breast cancer research : BCR 2020 Aug 22(1) 90
• Implementation of a High-Risk Breast Clinic for Comprehensive Care of Women With Elevated Breast Cancer Risk Identified by Risk Assessment Models in the Community. 
  Laws Alison et al. JCO oncology practice 2020 Aug OP2000256